Environmental and Host Factors in Testicular Germ Cell Tumors

REFERENCES

• Wingo P. A., Ries L. A.G., Giovino V. A., Miller D. S., Rosenberg H. M., Shopland D. R., Thun M. J., Edwards B. K. The Annual Report to the Nation on the Status of Cancer, 1973–1996 with a Special Section on Lung Cancer and Tobacco Smoking. J. Natl. Cancer Inst. 1999; 91: 675–690
   PubMed Web of Science ®Google Scholar
• Schottenfeld D. Testicular Cancer. Cancer Epidemiology and Prevention, D. Schottenfeld, J. F. Fraumeni, Jr. Oxford University Press, New York, NY 1996; 1207–1219
   Google Scholar
• Greenlee R. T., Hill-Harmon M. B., Murray T., Thun M. Cancer Statistics 2001. CA Cancer J. Clin. 2001; 51: 15–36
   PubMed Web of Science ®Google Scholar
• IARC. Cancer Incidence in Five Continents. IARC Scientific Publications No. 143, IARC, LyonFrance 1997; VII
   Google Scholar
• Wilkinson T. J., Colls B. M., Schluter P. J. Increased Incidence of Germ Cell Testicular Cancer in New Zealand Maoris. Br. J. Cancer 1992; 65: 769–771
   PubMed Web of Science ®Google Scholar
• SEER Cancer Statistics Review, 1973–1996, L. A.G. Ries, C. L. Kosary, B. F. Hankey, B. A. Miller, L. Clegg, B. K. Edwards. National Cancer Institute, National Institutes of Health, Bethesda, MD 1999
   Google Scholar
• Weir H. K., Marrett L. D., Moravan V. Trends in the Incidence of Testicular Germ Cell Cancer in Ontario by Histologic Subgroup, 1964–1996. CMAJ 1999; 160: 201–205
   PubMed Web of Science ®Google Scholar
• Wanderas E. H., Tretli S., Fossa S. D. Trends in Incidence of Testicular Cancer in Norway 1955–1992. Eur. J. Cancer 1995; 31A: 2044–2048
   PubMed Web of Science ®Google Scholar
• Bergstrom R., Adami H-O., Mohner M., Zatonski W., Storm H., Ekbom A., Tretli S., Tepp L., Akre O., Hakulinen T. Increase in Testicular Cancer Incidence in Six European Countries: A Birth Cohort Phenomenon. J. Natl. Cancer Inst. 1996; 88: 727–733
   PubMed Web of Science ®Google Scholar
• Stone J. M., Cruickshank D. G., Sandeman T. F., Matthews J. P. Laterality, Maldescent, Trauma and Other Clinical Factors in the Epidemiology of Testis Cancer in Victoria, Australia. Br. J. Cancer 1991; 64: 132–138
   PubMed Web of Science ®Google Scholar
• Zheng T., Holford T. R., Ma Z., Ward B. A., Flannery J., Boyle P. Continuing Increase in Incidence of Germ-Cell Testis Cancer in Young Adults: Experience from Connecticut, USA, 1935–1992. Int. J. Cancer 1996; 65: 723–729
   PubMed Web of Science ®Google Scholar
• Pharris-Ciurej N. D., Cook L. S., Weiss N. S. Incidence of Testicular Cancer in the United States: Has the Epidemic Begun to Abate. Am J. Epidemiol. 1999; 150: 45–46
   PubMed Web of Science ®Google Scholar
• Ekbom A., Akre O. Increasing Incidence of Testicular Cancer—Birth Cohort Effects. APMIS 1998; 106: 225–231
   PubMed Web of Science ®Google Scholar
• United Kingdom Testicular Cancer Study Group. Aetiology of Testicular Cancer: Associations with Congenital Abnormalities, Age at Puberty, Infertility, and Exercise. Br. Med. J. 1994; 308: 1393–1399, (abstract)
   Google Scholar
• Batata M. A., Chu F. C., Hilaris B. C., Whitmore W. F., Golbey R. B. Testicular Cancer in Cryptorchids. Cancer 1982; 49: 1023–1030
   PubMed Web of Science ®Google Scholar
• Berkowitz G. S., Lapinski R. H., Godbold J. H., Dolgin S. E., Holzman I. R. Maternal and Neonatal Risk Factors for Cryptorchidism. Epidemiology 1995; 6: 127–131
   PubMed Web of Science ®Google Scholar
• Ginsburg J. Unanswered Questions in Carcinoma of the Testis. Lancet 1997; 349: 1785–1786
   PubMed Web of Science ®Google Scholar
• Clemmensen J. Statistical Studies in the Etiology of Malignant Neoplasms. III. Testis cancer. Acta Pathol. Microbiol. Scand. 1969; 209(suppl)15–43
   Google Scholar
• Chilvers C. E.D., Pike M. C. Epidemiology of Undescended Testis. Urological and Genital Cancer, R. T.D. Oliver, J. P. Blandy, H. F. Hope-Stone. Blackwell Scientific Publications, Oxford 1989; 306–321
   Google Scholar
• Depue R. H. Maternal and Gestational Factors Affecting the Risk of Cryptorchism and Inguinal Hernia. Int. J. Epidemiol. 1984; 13: 311–318
   PubMed Web of Science ®Google Scholar
• Gallagher R. P., Huchcroft S., Phillips N., Hill G. B., Coldman A. J., Coppin C., Lee T. Physical Activity, Medical History, and Risk of Testicular Cancer (Alberta and British Columbia, Canada). Cancer Causes Control 1995; 6: 398–406
   PubMed Web of Science ®Google Scholar
• Gershman S. T., Stolley P. D. A Case-Control Study of Testicular Cancer Using Connecticut Tumor Registry Data. Int. J. Epidemiol. 1988; 17: 738–742
   PubMed Web of Science ®Google Scholar
• Brown L. M., Pottern L. M., Hoover R. N. Prenatal and Perinatal Risk Factors for Testicular Cancer. Cancer Res. 1986; 46: 4812–4816
   PubMed Web of Science ®Google Scholar
• Akre O., Ekbom A., Hsieh C-C., Trichopoulos D., Adami H-O. Testicular Nonseminoma and Seminoma in Relation to Perinatal Characteristics. J. Natl. Cancer Inst. 1996; 88: 883–889
   PubMed Web of Science ®Google Scholar
• Swerdlow A. J., Huttly S. R.A., Smith P. G. Prenatal and Familial Associations of Testicular Cancer. Br. J. Cancer 1987; 55: 571–577
   PubMed Web of Science ®Google Scholar
• Prener A., Hsieh C-C., Engholm G., Trichopoulos D., Jensen O. M. Birth Order and Risk of Testicular Cancer. Cancer Causes Control 1992; 3: 265–272
   PubMed Web of Science ®Google Scholar
• Braun M. M., Ahlbom A., Floderus B., Brinton L. A., Hoover R. N. Effect of Twinship on Incidence of Cancer of the Testis, Breast, and Other Sites (Sweden). Cancer Causes Control 1995; 6: 519–524
   PubMed Web of Science ®Google Scholar
• Satge D., Sasco A. J., Cure H., Leduc B., Sommelet D., Vekemans M. J. An Excess of Testicular Germ Cell Tumors in Down's Syndrome: Three Case Reports and a Review of the Literature. Cancer 1997; 80: 929–935
   PubMed Web of Science ®Google Scholar
• Petridou E., Roukas K. I., Dessypris N., Aravantinos G., Bafaloukos D., Epraimidis A., Papachralambous A., Pektasidis D., Rigatos G., Trichopoulos D. Baldness and Other Correlates of Sex Hormones in Relation to Testicular Cancer. Int. J. Cancer 1997; 71: 982–985
   PubMed Web of Science ®Google Scholar
• Depue R. H., Pike M. C., Henderson B. E. Estrogen Exposure During Gestation and Risk of Testicular Cancer. J. Natl. Cancer Inst. 1983; 71: 1151–1155
   PubMed Web of Science ®Google Scholar
• Coupland C. A.C., Chilvers C. E.D., Davey G., Pike M. C., Oliver R. T.D., Forman D. Risk Factors for Testicular Germ Cell Tumours by Histological Tumour Type. Br. J. Cancer 1999; 80: 1859–1863
   PubMed Web of Science ®Google Scholar
• United Kingdom Testicular Cancer Study Group. Social, Behavioural and Medical Factors in the Aetiology of Testicular Cancer: Results from the UK Study. Br. J. Cancer 1994; 70: 513–520
   Google Scholar
• Moss A. R., Osmond D., Bacchetti P., Torti F., Gurgin V. Hormonal Risk Factors in Testicular Cancer: A Case-Control Study. Am. J. Epidemiol. 1986; 124: 39–52
   PubMed Web of Science ®Google Scholar
• Swerdlow A. J., Higgins C. D., Pike M. C. Risk of Testicular Cancer in a Cohort of Boys with Cryptorchidism. Br. Med. J. 1997; 314: 1507–1511
   PubMed Web of Science ®Google Scholar
• Moller H., Skakkebaek N. E. Risks of Testicular Cancer and Cryptorchism in Relation to Socio-Economic Status and Related Factors: Case-Control Studies in Denmark. Int. J. Cancer 1996; 66: 287–293
   PubMed Web of Science ®Google Scholar
• Coldman A. J., Elwood J. M., Gallagher R. P. Sports Activities and Risk of Testicular Cancer. Br. J. Cancer 1982; 46: 749–756
   PubMed Web of Science ®Google Scholar
• Thune I., Lung E. Physical Activity and the Risk of Prostate and Testicular Cancer: A Cohort Study of 53,000 Norwegian Men. Cancer Causes Control 1994; 5: 549–556
   PubMed Web of Science ®Google Scholar
• Kemper H. C., Post G. B., Twisk J. W. Rate of Maturation During the Teenage Years: Nutrient Intake and Physical Activity Between the Ages of 12 and 22. Int. J. Sport Nutr. 1997; 7: 229–240
   PubMed Web of Science ®Google Scholar
• Hackney A. C., Premo M. C., McMurray R. G. Influence of Aerobic Versus Anaerobic Exercise on the Relationship Between Reproductive Hormones in Men. J. Sports Sci. 1995; 13: 305–311
   PubMedGoogle Scholar
• Dubrow R., Wegman D. H. Setting Priorities for Occupational Research and Control: Synthesis of the Results of Occupational Disease Surveillance Studies. J. Natl. Cancer Inst. 1983; 71: 1123–1142
   PubMed Web of Science ®Google Scholar
• Garland F. C., Gorham E. D., Garland C. F., Ducatman A. M. Testicular Cancer in US Navy Personnel. Am. J. Epidemiol. 1988; 127: 411–414
   PubMed Web of Science ®Google Scholar
• McDowell M. E., Balarajan R. Testicular Cancer Mortality in England and Wales 1971–1980: Variations by Occupation. J. Epidemiol. Community Health 1986; 40: 26–29
   PubMed Web of Science ®Google Scholar
• Brown L., Pottern L. Testicular Cancer and Farming. Lancet 1984; 1: 1356
   PubMed Web of Science ®Google Scholar
• Levin S. M., Baker D. B., Landrigan P. J., et al. Testicular Cancer in Leather Tanners Exposed to Dimethylformamide. Lancet 1987; ii: 1153
   Google Scholar
• Ducatman A. M., Conwill D. E., Crawl J. Germ Cell Tumors of the Testicle Among Aircraft Repairmen. J. Urol. 1986; 136: 834–836
   PubMed Web of Science ®Google Scholar
• Rose L. I., Weiss W., Gibley C. W, Borowski G., Levy R. A. Carcinoma of the Testis in Podiatrists. Ann. Intern. Med. 1983; 99: 636–637
   PubMed Web of Science ®Google Scholar
• Davis R. L., Mostofi F. K. Cluster of Testicular Cancer in Police Officers Exposed to Hand-Held Radar. Am. J. Ind. Med. 1993; 24: 231–233
   PubMed Web of Science ®Google Scholar
• Armstrong B., Doll R. Environmental Factors and Cancer Incidence and Mortality in Different Countries, with Special Reference to Dietary Practices. Int. J. Cancer 1975; 15: 617–631
   PubMed Web of Science ®Google Scholar
• Davies T. W., Palmer C. R., Ruja E., Lipscombe J. M. Adolescent Milk, Dairy Product and Fruit Consumption and Testicular Cancer. Br. J. Cancer 1996; 74: 657–660
   PubMed Web of Science ®Google Scholar
• Moul J. W., Schanne F. J., Thompson I. M., Fraxier H. A., Peretsman S. A., Wettlaufer J. N., Rozanski T. A., Stack R. S., Kreder K. J., Hoffman K. J. Testicular Cancer in Blacks: A Multicenter Experience. Cancer 1994; 73: 388–393
   PubMed Web of Science ®Google Scholar
• Henderson B. E., Bernstein L., Ross R. K., Depue R. H., Judd H. L. The Early in Utero Oestrogen and Testosterone Environment of Blacks and Whites: Potential Effects on Male Offspring. Br. J. Cancer 1988; 57: 216–218
   PubMed Web of Science ®Google Scholar
• Wilkinson T. J., Colls B. M. Testicular Cancer in Blacks: A Multicenter Experience. Cancer 1994; 74: 1649
   PubMed Web of Science ®Google Scholar
• Swerdlow A. J., Marmot M. G., Grulich A. E., Head J. Cancer Mortality in Indian and British Ethnic Immigrants from the Indian Subcontinent to England and Wales. Br. J. Cancer 1995; 72: 1312–1319
   PubMed Web of Science ®Google Scholar
• Parkin D. M., Iscovich J. Risk of Cancer in Migrants and Their Descendants in Israel: II. Carcinomas and Germ-Cell Tumours. Int. J. Cancer 1997; 70: 654–660
   PubMed Web of Science ®Google Scholar
• Moller H. Clues to the Aetiology of Testicular Germ Cell Tumours from Descriptive Epidemiology. Eur. Urol. 1993; 23: 8–15
   PubMed Web of Science ®Google Scholar
• Morrison A. S. Cryptorchism, Hernia and Cancer of the Testis. J. Natl. Cancer Inst. 1976; 56: 731–733
   PubMed Web of Science ®Google Scholar
• Prener A., Engholm G., Jensen O. M. Genital Anomalies and Risk for Testicular Cancer in Danish Men. Epidemiology 1996; 7: 14–19
   PubMed Web of Science ®Google Scholar
• Haughey B., Graham S., Brasure J., Zielezny M., Sufrin G., Burnett W. S. The Epidemiology of Testicular Cancer in Upstate New York. Am. J. Epidemiol. 1989; 130: 25–36
   PubMed Web of Science ®Google Scholar
• Golden R. J., Noller K. L., Titus-Ernstoff L., Kaufman R. H., Mittendorf R., Stillman R., Reese E. A. Environmental Endocrine Modulators and Human Health: An Assessment of the Biological Evidence. Crit. Rev. Toxicol. 1998; 28: 109–227
   PubMed Web of Science ®Google Scholar
• Kelce W. R., Stone C. R., Laws S. C., Earl-Gray L., Kemppainen J. A., Wilson E. M. Persistent DDT Metabolite p,p'-DDE Is a Potent Androgen Receptor Antagonist. Nature 1995; 375: 581–585
   PubMed Web of Science ®Google Scholar
• Cocco P., Benichou J. Mortality from Cancer of the Male Reproductive Tract and Environmental Exposure to the Anti-androgen p,p'-dichlorodiphenyldichloroethylene in the United States. Oncology 1998; 55: 334–339
   PubMed Web of Science ®Google Scholar
• Newbold R. R., Bullock B. C., McLachlan J. A. Lesions of the Rete Testis in Mice Exposed Prenatally to Diethylstilbestrol. Cancer Res. 1985; 45: 5145–5150
   PubMed Web of Science ®Google Scholar
• Loughlin J. E., Robboy S. J., Morrison A. S. Risk Factors for Cancer of the Testis. N. Engl. J. Med. 1980; 303: 112–113
   PubMed Web of Science ®Google Scholar
• Hatch E. E., Hartge P., Hoover R. N. NCI Combined Intramural Principal Investigator Retreat 1999. Cancer Risks in Mothers, Daughters, and Sons Exposed to Diethylstilbestrol During Pregnancy. National Cancer Institute, Chantilly, VA 1999; 35
   Google Scholar
• Giusti R. M., Iwamoto K., Hatch E. E. Diethylstilbestrol Revisited: A Review of the Long-Term Health Effects. Ann. Intern. Med. 1995; 122: 778–788
   PubMed Web of Science ®Google Scholar
• Buetow S. Epidemiology of Testicular Cancer. Epidemiol. Rev. 1995; 17: 433–449
   PubMed Web of Science ®Google Scholar
• Bernstein L., Depue R. H., Ross R. K., Judd H. L., Pike M. C., Henderson B. E. Higher Maternal Levels of Free Estradiol in First Compared to Second Pregnancy: Early Gestational Differences. J. Natl. Cancer Inst. 1986; 76: 1035–1039
   PubMed Web of Science ®Google Scholar
• Yang C., Chen S. Two Organochlorine Pesticides, Toxaphene and Chlordane, Are Antagonists for Estrogen-Related Receptor α-1 Orphan Receptor. Cancer Res. 1999; 59: 4519–4524
   PubMed Web of Science ®Google Scholar
• Parker L. Causes of Testicular Cancer. Lancet 1997; 350: 827–828
   PubMed Web of Science ®Google Scholar
• Petersen P. M., Skakkebaek N. E., Vistisen K., Rorth M., Giwercman A. Semen Quality and Reproductive Hormones Before Orchiectomy in Men with Testicular Cancer. J. Clin. Oncol. 1999; 17: 941–947
   PubMed Web of Science ®Google Scholar
• Lee P. A., Bellinger M. F., Coughlin M. T. Correlations Among Hormone Levels, Sperm Parameters and Paternity in Formerly Unilaterally Cryptorchid Men. J. Urol. 1998; 160: 1155–1158
   PubMed Web of Science ®Google Scholar
• Oliver R. T.D. Atrophy, Hormones, Genes and Viruses in Aetiology of Germ Cell Tumours. Cancer Surv. 1990; 9: 263–286
   PubMedGoogle Scholar
• Newell G. R., Mills P. K., Johnson D. E. Epidemiologic Comparison of Cancer of the Testis and Hodgkin's Disease Among Young Males. Cancer 1984; 54: 1117–1123
   PubMed Web of Science ®Google Scholar
• Algood C. B., Newell G. R., Johnson D. E. Viral Etiology of Testicular Tumors. J. Urol. 1988; 139: 308–310
   PubMed Web of Science ®Google Scholar
• Mueller N., Hinkula J., Wahren B. Elevated Antibody Titers Against Cytomegalovirus Among Patients with Testicular Cancer. Int. J. Cancer 1988; 41: 399–403
   PubMed Web of Science ®Google Scholar
• Akre O., Lipworth L., Tretli S., Linde A., Engstrand L., Adami H-O., Melbye M., Andersen A., Ekbom A. Epstein-Barr Virus and Cytomegalovirus in Relation to Testicular Cancer Risk: A Nested Case-Control Study. Int. J. Cancer 1999; 82: 1–5
   PubMed Web of Science ®Google Scholar
• Brown L. M., Pottern L. M., Hoover R. N. Testicular Cancer in Young Men: The Search for Causes of the Epidemic Increase in the United States. J. Epidemiol. Community Health 1987; 41: 349–354
   PubMed Web of Science ®Google Scholar
• Muganda P., Mendoza O., Hernandez J., Qian Q. Human Cytomegalovirus Elevates Levels of the Cellular Protein p53 in Infected Fibroblasts. J. Virol. 1994; 68: 8028–8034
   PubMed Web of Science ®Google Scholar
• Morris J. D., Eddleston A. L., Crook T. Viral Infection and Cancer. Lancet 1995; 754–758
   PubMed Web of Science ®Google Scholar
• Gray A., Guillou L., Zufferey J., Rey F., Kurt A-M., Jichlinski P., Leisinger H-J., Benhattar J. Persistence of Parvovirus B19 DNA in Testis of Patients with Testicular Germ Cell Tumors. J. Gen. Virol. 1998; 79: 573–578
   PubMed Web of Science ®Google Scholar
• Leib-Mosch C., Brack-Werner R., Werner T., Backmann M., Fuff O., Erfle V., Ilehlmann R. Endogenous Retroviral Elements in Human DNA. Cancer Res. 1990; 50: 5636s–5642s
   Google Scholar
• Lower R., Lower J., Kurth R. The Viruses in All of Us: Characteristics and Biological Significance of Human Endogenous Retrovirus Sequences. Proc. Natl. Acad. Sci. U.S.A. 1996; 93: 5177–5184
   PubMed Web of Science ®Google Scholar
• Lower R., Boller K., Hasenmaier B., Korbmacher C., Mueller-Lantzsch N., Lower J., Kurth R. Identification of Human Endogenous Retroviruses with Complex mRNA Expression and Particle Formation. Proc. Natl. Acad. Sci. U.S.A. 1993; 90: 4480–4484
   PubMed Web of Science ®Google Scholar
• Sauter M., Schommer S., Kremmer E., Remberger K., Dolken G., Lemm I., Buck M., Best B., Neumann-Haefelin D., Mueller-Lantzsch N. Human Endogenous Retrovirus K10: Expression of Gag Protein and Detection of Antibodies in Patients with Seminoma. J. Virol. 1995; 69: 414–421
   PubMed Web of Science ®Google Scholar
• Herbst H., Sauter M., Kuhler-Obbarius C., Loning T., Mueller-Lantzsch N. Human Endogenous Retrovirus (HERV)-K Transcripts in Germ Cell and Trophoblastic Tumours. APMIS 1998; 106: 216–220
   PubMed Web of Science ®Google Scholar
• Ono M., Kawakami M., Ushikubo H. Stimulation of Expression of the Human Endogenous Retrovirus Genome by Female Steroid Hormones in Human Breast Cancer Cell Line T47D. J. Virol. 1987; 61: 2059–2062
   PubMed Web of Science ®Google Scholar
• Goedert J. J., Sauter M. E., Jacobson L. P., Vessella R. L., Hilgartner M. W., Leitman S. F., Fraser M. C., Mueller-Lantzsch N. G. High Prevalence of Antibodies Against HERV-K10 in Patients with Testicular Cancer but Not with AIDS. Cancer Epidemiol. Biomarkers Prev. 1999; 8: 292–296
   Google Scholar
• DeWolf W. C., Lange P. H., Einarson M. E., Yunis E. J. HLA and Testicular Cancer. Nature 1979; 277: 216–217
   PubMed Web of Science ®Google Scholar
• Dieckmann K. P., Klan R., Bunte S. HLA Antigens, Lewis Antigens, and Blood Groups in Patients with Testicular Germ Cell Tumors. Oncology 1993; 50: 252–258
   PubMed Web of Science ®Google Scholar
• Kratzik C., Aiginger P., Kuber W., Riccabona M., Kuhrer I., Joos H., Frick J., Amann G., Mayr W. Risk Factors for Bilateral Testicular Germ Cell Tumors. Does Heredity Play a Role? Cancer 1991; 68: 916–921
   Google Scholar
• Ozdemir E., Kakehi Y., Mishina M., Ogawa O., Okada Y., Ozdemir D., Yoshida O. High-Resolution HLA-DRB1 and DQB1 Genotyping in Japanese Patients with Testicular Germ Cell Carcinoma. Br. J. Cancer 1997; 76: 1348–1352
   PubMed Web of Science ®Google Scholar
• Majsky A., Abrahamova J., Korinkova P., Bek V. HLA System and Testicular Germinative Tumours. Oncology 1979; 36: 228–231
   PubMed Web of Science ®Google Scholar
• Forman D., Oliver R. T.D., Brett A. R., Marsh S. G.E., Moses J. H., Bodmer J. G., Chilvers C. E.D., Pike M. C. Familial Testicular Cancer: A Report of the UK Family Register, Estimation of Risk and an HLA Class 1 Sib-Pair Analysis. Br. J. Cancer 1992; 65: 255–262
   PubMed Web of Science ®Google Scholar
• Ryberg D., Heimdal K., Fossa S. D., Borresen A-L., Haugen A. Rare Ha-ras1 Alleles and Predisposition to Testicular Cancer. Int. J. Cancer 1993; 53: 938–940
   PubMed Web of Science ®Google Scholar
• Heimdal K., Lothe R. A., Fossa S. D., Borresen A-L. Association Studies of a Polymorphism in the Wilms' Tumor 1 Locus in Norwegian Patients with Testicular Cancer. Int. J. Cancer 1994; 58: 523–526
   PubMed Web of Science ®Google Scholar
• Heimdal K., Andersen T. I., Skrede M., Fossa S. D., Berg K., Borresen A-L. Association Studies of Estrogen Receptor Polymorphisms in a Norwegian Testicular Cancer Population. Cancer Epidemiol. Biomarkers Prev. 1995; 4: 123–126
   PubMed Web of Science ®Google Scholar
• Vistisen K., Prieme H., Okkels H., Vallentin S., Loft S., Olsen J. H., Poulsen H. E. Genotype and Phenotype of Glutathione-S-Transferase μ in Testicular Cancer Patients. Pharmacogenetics 1997; 7: 21–25
   PubMedGoogle Scholar
• Harries L. W., Stubbins M. J., Forman D., Howard G. C., Wolf C. R. Identification of Genetic Polymorphisms at the Glutathione-S-Transferase πLocus and Association with Susceptibility to Bladder, Testicular and Prostate Cancers. Carcinogenesis 1997; 18: 641–644
   PubMed Web of Science ®Google Scholar
• Hayes J. D., Pulford D. J. The Glutathione-S-Transferase Supergene Family: Regulation of GST and the Contribution of the Isoenzymes to Cancer Chemoprevention and Drug Resistance. Crit. Rev. Biochem. Mol. Biol. 1995; 30: 445–600
   PubMed Web of Science ®Google Scholar
• Katagiri A., Tomita Y., Nishiyama T., Kimura M., Sato S. Immunohistochemical Detection of P-Glycoprotein and GSTP1-1 in Testis Cancer. Br. J. Cancer 1993; 68: 125–129
   PubMed Web of Science ®Google Scholar
• Heimdal K., Olsson H., Tretli S., Flodgren P., Borresen A-L., Fossa S. D. Familial Testicular Cancer in Norway and Sweden. Br. J. Cancer 1996; 73: 964–969
   PubMed Web of Science ®Google Scholar
• Westergaard T., Olsen J. H., Frisch M., Kroman N., Nielsen J. W., Melbye M. Cancer Risk in Fathers and Brothers of Testicular Cancer Patients in Denmark. A Population-Based Study. Int. J. Cancer 1996; 66: 627–631
   PubMed Web of Science ®Google Scholar
• Hopper J. L., Carlin J. B. Familial Aggregation of a Disease Consequent upon Correlation Between Relatives in a Risk Factor Measured on a Continuous Scale. Am. J. Epidemiol. 1992; 136: 1138–1147
   PubMed Web of Science ®Google Scholar
• International Testicular Cancer Linkage Consortium. Candidate Regions for Testicular Cancer Susceptibility Genes. APMIS 1998; 106: 64–72
   PubMedGoogle Scholar
• Rapley E. A., Crockford G. P., Teare D., Biggs P., Seal S., Barfoot R., Edwards S., Hamoudi R., Heimdal K., Fossa S. D., Tucker K., Donald J., Collins F., Friedlander M., Hogg D., Goss P., Heidenreich A., Ormiston W., Daly P. A., Forman D., Oliver R. T.D., Leahy M., Huddart R., Cooper C. S., Bodmer J. G., Easton D. E., Stratton M. R., Bishop D. T. Localization to Xq27 of a Susceptibility Gene for Testicular Germ-Cell Tumours. Nat. Genet. 2000; 24: 197–200
   PubMed Web of Science ®Google Scholar
• Swerdlow A. J., De Stavola B. L., Swanwick M. A., Maconochie N. E.S. Risks of Breast and Testicular Cancers in Young Adult Twins in England and Wales: Evidence on Prenatal and Perinatal and Genetic Aetiology. Lancet 1997; 350: 1723–1728
   PubMed Web of Science ®Google Scholar
• Lambalk C. B., Boomsma D. I. Genetic Risk Factors in Tumours of the Testis: Lessons from Twin Studies. Twin Res. 1998; 1: 154–155
   PubMedGoogle Scholar
• van Montfrans J. M., Dorland M., Oosterhuis G. J.E., van Vugt J. M., Rekers-Mombard L. T.M., Lambalk C. B. Increased Concentrations of Follicle Stimulating Hormone in Mothers of Children with Down's Syndrome. Lancet 1999; 353: 1853–1854
   PubMed Web of Science ®Google Scholar
• Sicinski P., Donaher J. L., Geng Y., Parker S. B., Gardner H., Park M. Y., Robker R. L., Richards J. S., McGinnis L. K., Biggers J. D., Eppig J. J., Bronson R. T., Elledge S. J., Weinberg R. A. Cyclin D2 Is an FSH-Responsive Gene Involved in Gonadal Cell Proliferation and Oncogenesis. Nature 1996; 384: 470–474
   PubMed Web of Science ®Google Scholar
• Heimdal K., Olsson H., Tretli S., Fossa S. D., Borresen A-L., Bishop D. T. A Segregation Analysis of Testicular Cancer Based on Norwegian and Swedish Families. Br. J. Cancer 1997; 75: 1084–1087
   PubMed Web of Science ®Google Scholar
• Nicholson P. W., Harland S. J. Inheritance and Testicular Cancer. Br. J. Cancer 1995; 71: 421–426
   PubMed Web of Science ®Google Scholar
• Murty V. V.V.S., Chaganti R. S.K. A Genetic Perspective of Male Germ Cell Tumours. Semin. Oncol. 1998; 25: 133–144
   PubMed Web of Science ®Google Scholar
• Chaganti R. S.K., Rodriquez E., Bosl G. J. Cytogenetics of Male Germ Cell Tumors. Urol. Clin. N. Am 1993; 20: 55–66
   PubMed Web of Science ®Google Scholar
• Rodriguez E., Mathew S., Reuter V., Ilson D. H., Bosl G. J., Chaganti R. S. Cytogenetic Analysis of 124 Prospectively Ascertained Male Germ Cell Tumors. Cancer Res. 1992; 52: 2285–2291
   PubMed Web of Science ®Google Scholar
• Houldsworth J., Reuter V., Bosl G. J., Chaganti R. S.K. Aberrant Expression of Cyclin D2 Is an Early Event in Human Male Germ Cell Tumorigenesis. Cell Growth Differ. 1997; 8: 293–299
   PubMedGoogle Scholar
• Samaniego F., Rodriguez E., Houldsworth J., Murty V. V., Ladanyi M., Lele K. P., Chen Q. G., Dmitrovsky E., Geller N. L., Reuter V. Cytogenetic and Molecular Analysis of Human Male Germ Cell Tumors: Chromosome 12 Abnormalities and Gene Amplification. Genes Chromosomes Cancer 1990; 1: 289–300
   PubMed Web of Science ®Google Scholar
• Peng H-Q., Bailey D., Bronson D., Gross P. E., Hogg D. Loss of Heterozygosity of Tumor Suppressor Genes in Testis Cancer. Cancer Res. 1995; 55: 2871–2875
   PubMed Web of Science ®Google Scholar
• Al-Jehani R. M.J., Povey S., Delhanty J. D.A., Parrington J. M. Loss of Heterozygosity on Chromosome Arms 5q, 11p, 11q, 13q, and 16p in Human Testicular Germ Cell Tumors. Genes Chromosomes Cancer 1995; 13: 2249–2256
   Google Scholar
• Lutzker S. G. P53 Tumour Suppressor Gene and Germ Cell Neoplasia. A.P.M.I.S. 1998; 106: 85–89
   Google Scholar
• Fleischhacker M., Strohmeyer T., Imai Y., Slamon D. J., Koeffler H. P. Mutations of the p53 Gene Are Not Detectable in Human Testicular Tumors. Mod. Pathol. 1994; 7: 435–439
   PubMed Web of Science ®Google Scholar